These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20669562)

  • 1. [New insights into neuroendocrine tumors: molecular biology, imaging and targeted therapies].
    Rohmer V
    Bull Acad Natl Med; 2010 Jan; 194(1):97-104; discussion 104-5. PubMed ID: 20669562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic alternatives in metastatic neuroendocrine tumors.
    Miller CA; Ellison EC
    Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of non-functioning pancreatic islet cell tumors.
    Kouvaraki MA; Solorzano CC; Shapiro SE; Yao JC; Perrier ND; Lee JE; Evans DB
    J Surg Oncol; 2005 Mar; 89(3):170-85. PubMed ID: 15719379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal neuroendocrine neoplasias: novel individualized therapeutic strategies].
    Pape UF; Pascher A; Arsenic R; Ezziddin S; Jann H; Pavel ME; Wiedenmann B
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1801-6. PubMed ID: 21882138
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.
    Oberg K
    Curr Opin Oncol; 1994 Jul; 6(4):441-51. PubMed ID: 7803546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
    Nakakura EK; Venook AP; Bergsland EK
    Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic therapy of gastroenteropancreatic (GEP) tumors.
    Syrigos KN; Sitara D; Georgiou E; Harrington KJ
    Anticancer Res; 2002; 22(2B):1311-4. PubMed ID: 12168943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Locoregional therapy of neuroendocrine tumors].
    Roche A; Lasser P
    Rev Prat; 2002 Feb; 52(3):274-8. PubMed ID: 11925717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of peritoneal metastasis from neuroendocrine tumors.
    Au JT; Levine J; Aytaman A; Weber T; Serafini F
    J Surg Oncol; 2013 Nov; 108(6):385-6. PubMed ID: 24142576
    [No Abstract]   [Full Text] [Related]  

  • 17. Future perspectives on neuroendocrine tumors.
    Castellano D; Salazar R; Raymond E
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():35-40. PubMed ID: 21327890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.